Tc1 cells percentage in patients with cutaneous Leishmaniasis before and after treatment with glucantime

Iranian Journal of Public Health

Volumn 36, Issue 1, 2007, Pages 55-61

  Mohajery, M ^a   Shamsian, A A ^a   Mahmoodi, M ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; Flow cytometry; Glucantime and lymphocyte; Tc1

Indexed keywords

EID: 33947519369     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organization (updated 2002). Division of Control of Tropical Diseases. Leishmaniasis control. available from: www.who.int/ health-topics/leishmaniasis
2. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006). Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant leishmania tropica parasites. Plo S Med, 3(5): p. 162.
3. Ajdary S, Alimohammadian MH, Eslami MB, Kemp K, Kharazmi A (2000). Comparison of the immune profile of non-healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun, 68: 1760-4.
4. Santiago MA, Luca PM, Berth AL, Azeredocoutinho RB, Coutinho SG (2000). Detection of intracytoplasmic cytokines by Flow Cytometry. Mem Inst Oswaldo Cruz, 95(3):401-2.
5. Dekrey GK, Titus RG (1999). A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesion in mice. J Immunol Methods, 228: 1-11.
6. Pearson RD, Sousa AQ, Jeronimo SM (2000). Cutaneous and mucosal leishmaniasis in: Principles and practice of Infection Disease. Eds, Gerald L, Mandell JE, Benner RD 5th ed., vol 5. Philadelphia Churchill Livingstone, England, pp.: 2830-41
7. Wijeyarme P, Goodman T, Espinal C (1992). Leishmanisis control strategies. Parasitology Today, 8:249-251.
8. Behin R, Mauel J, Sordat B (1979). Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp Parasit, 48: 81-91.
9. Handrian P, Rook A (1979). Leishmaniasis in: Textbook of Dermatology. Eds, Rook A, Wilkinson DS, Ebling FJ, Oxford Blackwell Scientific publication. England, 3rd ed, pp. 901-4.
10. Virella G (1990). Immunological aspect of the host-parasite relationship. In: Introduction to medical Immunology. Eds, Virella G, Goust J M and Fundenberg. 4th ed. Marcel Dekker Inc. New York, pp. 239-57.
11. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989). Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T-cell subsets. J Esp Med. 169: 59-72.
12. Mosman TR, Cherwinski H, Bond MW, Ciedlin MA, Coffiman RL (1989). Two types of murine helper T cell clone I: Definition according to profiles of lymphokine activities and secreted proteins, J Immunol, 136: 2348-57.
13. Abbas AK, Murphy KM, Sher A (1996). Functional diversity of helper T lymphocytes. Nature, 383: 787-793.
14. Reed SG, Scott P (1993). T cell and cytokine responses in leishmaniasis. Curr Opin Immunol, 5: 524-31.
15. Pinelli E, Gonzalo RM, Boog CJ, Rotten VP, Gebbard D, DelReal G, Ruitenberg EJ (1995). Leishmania infantum-specific T cell lines derived from symptomatic dogs that lyses infected macrophages in major histocompatibility complex restricted manner. Eur J Immunol, 25: 1594-600.
16. + cytotoxic effectors. Exp Parasitol, 93: 161-70.
17. Machado P, Araujo C, Da Silva AT, Almeida PR, D'Oliveira JrA, Bittencourt A, et al. (2002). Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis, 15: 69-73.
18. Diaz NL, Fernandez M, Figueira E, Mansalve I, Ramirez BR, Topia FJ (2003). Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis. Clin Exp Dematol, 28: 288-93.
19. Tscharke DC, Yewdell JW (2003). T cell bites the hand that feeds them. Nature Medicine, 9: 647-48.
20. + regulatory T cells control Leishmania major persistence and immunity. Nature, 420: 502-507.
21. Scott P (2003). Development and regulation of cell-mediated immunity in expertmental leishmaniasis. Immunol Res, 27(2-3): 489-498.
22. Kagi D, Ledemann B, Burki K et al. (1994). Cytotoxicity mediated by T cell and natural killer cells in greatly impaired in perforin-defcient, mice. Nature, 369: 31-34.
23. Wong P, Pamer EG (2003). Feed back regulation of pathogen-specific T cell priming immunity, 18: 499-511.
24. Vieira MG, Oliveira F, Arruda S, Bittencourt AL, Barbosa. AA Jr, Barral-Netto M, et al. (2002). B cell infiltration and frequency of cytokine producing cells differ between localized and disseminated human cutaneous leishmaniasis. Mem Inst Oswaldo Cruz, 97: 979-83.
25. + T cells. J Immunol, 165: 915-24.
26. Pompeu MM, Brodskyn C, Teixeira MJ, Clarencio J, Van Weyenberg J, Coelho I C, et al (2001). Difference in gamma interferon production in vitro predicts the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun, 69: 7453-7460.
27. Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M (1997). Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol, 159: 4467-73.